Drug intelligence / Profile preview

kunning granules

Development stage: Unknown
Lead developer: Hefei Everlife Pharmaceutical
Administration: Oral

Overview

Kunning Granules (坤宁颗粒) is a Traditional Chinese Medicine (TCM) product developed and manufactured by Hefei Everlife Pharmaceutical. Formulated as oral granules, it is primarily indicated for the treatment of gynecological conditions characterized by abnormal uterine bleeding, such as menorrhagia (heavy menstrual bleeding) and prolonged menstruation. The therapeutic action of Kunning Granules is based on TCM principles of cooling the blood to stop bleeding while simultaneously benefiting Qi and nourishing Yin. It is typically prescribed for patients whose bleeding is attributed to patterns of 'blood heat' or 'Qi and Yin deficiency,' helping to regulate the menstrual cycle and restore balance according to traditional medical practices.

Brand names: Kunning Granules
Other names: 坤宁颗粒Kunning Keli

Beyond the preview

Go deeper on kunning granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on kunning granules.

Explore the full profile